» Articles » PMID: 22016563

Phospholipase C and Protein Kinase C-β 2 Mediate Insulin-like Growth Factor II-dependent Sphingosine Kinase 1 Activation

Overview
Journal Mol Endocrinol
Date 2011 Oct 22
PMID 22016563
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We recently reported that IGF-II binding to the IGF-II/mannose-6-phosphate (M6P) receptor activates the ERK1/2 cascade by triggering sphingosine kinase 1 (SK1)-dependent transactivation of G protein-coupled sphingosine 1-phosphate (S1P) receptors. Here, we investigated the mechanism of IGF-II/M6P receptor-dependent sphingosine kinase 1 (SK1) activation in human embryonic kidney 293 cells. Pretreating cells with protein kinase C (PKC) inhibitor, bisindolylmaleimide-I, abolished IGF-II-stimulated translocation of green fluorescent protein (GFP)-tagged SK1 to the plasma membrane and activation of endogenous SK1, implicating PKC as an upstream regulator of SK1. Using confocal microscopy to examine membrane translocation of GFP-tagged PKCα, β1, β2, δ, and ζ, we found that IGF-II induced rapid, transient, and isoform-specific translocation of GFP-PKCβ2 to the plasma membrane. Immunoblotting of endogenous PKC phosphorylation confirmed PKCβ2 activation in response to IGF-II. Similarly, IGF-II stimulation caused persistent membrane translocation of the kinase-deficient GFP-PKCβ2 (K371R) mutant, which does not dissociate from the membrane after translocation. IGF-II stimulation increased diacylglycerol (DAG) levels, the established activator of classical PKC. Interestingly, the polyunsaturated fraction of DAG was increased, indicating involvement of phosphatidyl inositol/phospholipase C (PLC). Pretreating cells with the PLC inhibitor, U73122, attenuated IGF-II-dependent DAG production and PKCβ2 phosphorylation, blocked membrane translocation of the kinase-deficient GFP-PKCβ2 (K371R) mutant, and reduced sphingosine 1-phosphate production, suggesting that PLC/PKCβ2 are upstream regulators of SK1 in the pathway. Taken together, these data provide evidence that activation of PLC and PKCβ2 by the IGF-II/M6P receptor are required for the activation of SK1.

Citing Articles

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.


Dysglycemia With Impaired Insulin Secretion After Resection of a High-Molecular-Weight IGF-II-Producing Tumor.

Shimada Y, Yamashita K, Fukuda I, Aizawa T JCEM Case Rep. 2023; 1(1):luac013.

PMID: 37908273 PMC: 10578367. DOI: 10.1210/jcemcr/luac013.


A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.

Ueda N Int J Mol Sci. 2022; 23(7).

PMID: 35409370 PMC: 9000186. DOI: 10.3390/ijms23074010.


Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.

Tilak M, Holborn J, New L, Lalonde J, Jones N Int J Mol Sci. 2021; 22(4).

PMID: 33673213 PMC: 7918566. DOI: 10.3390/ijms22041831.


Cholecalciferol (Vitamin D) Reduces Rat Neuropathic Pain by Modulating Opioid Signaling.

Poisbeau P, Aouad M, Gazzo G, Lacaud A, Kemmel V, Landel V Mol Neurobiol. 2019; 56(10):7208-7221.

PMID: 31001801 DOI: 10.1007/s12035-019-1582-6.


References
1.
Hubbard K, Hepler J . Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell Signal. 2005; 18(2):135-50. DOI: 10.1016/j.cellsig.2005.08.004. View

2.
Johnson K, Becker K, Facchinetti M, Hannun Y, Obeid L . PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem. 2002; 277(38):35257-62. DOI: 10.1074/jbc.M203033200. View

3.
Doll F, Pfeilschifter J, Huwiler A . The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7. Biochim Biophys Acta. 2006; 1738(1-3):72-81. DOI: 10.1016/j.bbalip.2005.12.001. View

4.
Minniti C, Kohn E, Grubb J, Sly W, Oh Y, Muller H . The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem. 1992; 267(13):9000-4. View

5.
Chu C, Tzang B, Chen L, Liu C, Tsai F, Tsai C . Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through G(alpha)q and downstream calcineurin signaling in myocardial cells. Endocrinology. 2008; 150(6):2723-31. DOI: 10.1210/en.2008-0975. View